HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Factors influencing insulin resistance in relation to atherogenicity in mood disorders, the metabolic syndrome and tobacco use disorder.

AbstractOBJECTIVE:
This study examines the effects of malondialdehyde (MDA) and uric acid on insulin resistance and atherogenicity in subjects with and without mood disorders, the metabolic syndrome (MetS) and tobacco use disorder (TUD).
METHODS:
We included 314 subjects with depression and bipolar depression, with and without the MetS and TUD and computed insulin resistance using the updated homeostasis model assessment (HOMA2IR) and atherogenicity using the atherogenic index of plasma (AIP), that is log10 (triglycerides/high density lipoprotein (HDL) cholesterol.
RESULTS:
HOMA2IR is correlated with body mass index (BMI) and uric acid levels, but not with mood disorders and TUD, while the AIP is positively associated with BMI, mood disorders, TUD, uric acid, MDA and male sex. Uric acid is positively associated with insulin and triglycerides and negatively with HDL cholesterol. MDA is positively associated with triglyceride levels. Comorbid mood disorders and TUD further increase AIP but not insulin resistance. Glucose is positively associated with increasing age, male gender and BMI.
DISCUSSION:
The results show that mood disorders, TUD and BMI together with elevated levels of uric acid and MDA independently contribute to increased atherogenic potential, while BMI and uric acid are risk factors for insulin resistance. The findings show that mood disorders and TUD are closely related to an increased atherogenic potential but not to insulin resistance or the MetS. Increased uric acid is a highly significant risk factor for insulin resistance and increased atherogenic potential. MDA, a marker of lipid peroxidation, further contributes to different aspects of the atherogenic potential. Mood disorders and TUD increase triglyceride levels, lower HDL cholesterol and are strongly associated with the atherogenic, but not insulin resistance, component of the MetS.
AuthorsChiara Cristina Bortolasci, Heber Odebrecht Vargas, Sandra Odebrecht Vargas Nunes, Luiz Gustavo Piccoli de Melo, Márcia Regina Pizzo de Castro, Estefania Gastaldello Moreira, Seetal Dodd, Décio Sabbatini Barbosa, Michael Berk, Michael Maes
JournalJournal of affective disorders (J Affect Disord) Vol. 179 Pg. 148-55 (Jul 01 2015) ISSN: 1573-2517 [Electronic] Netherlands
PMID25863911 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2015 Elsevier B.V. All rights reserved.
Chemical References
  • Biomarkers
  • Blood Glucose
  • Cholesterol, HDL
  • Insulin
  • Triglycerides
  • Uric Acid
  • Malondialdehyde
Topics
  • Adolescent
  • Adult
  • Aged
  • Atherosclerosis (blood, complications)
  • Biomarkers (blood)
  • Bipolar Disorder (blood, complications)
  • Blood Glucose
  • Body Mass Index
  • Cholesterol, HDL (blood)
  • Depression (blood, complications)
  • Female
  • Humans
  • Insulin (blood)
  • Insulin Resistance
  • Male
  • Malondialdehyde
  • Metabolic Syndrome (blood, complications)
  • Middle Aged
  • Oxidative Stress
  • Risk Factors
  • Tobacco Use Disorder (blood, complications)
  • Triglycerides (blood)
  • Uric Acid (blood)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: